Metropolis Healthcare reported a strong 23% revenue growth for Q2FY26, mainly driven by preventive health check-ups; the company remains debt-free with a cash surplus of ~INR 55 crores and has acquired Ambika Pathology Laboratory effective September 18, 2025 to enhance operations in Kolhapur.